Business
Currency:EUR
2024/FY
Stock NameRevenueRatio
Discovery and development of innovative, RNA based therapeutics18.91M100.00%
Region
Currency:EUR
2024/FY
Stock NameRevenueRatio
United States18.91M100.00%